Stay updated on Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    Change Detected
    Summary
    The value on the webpage has been updated from 2023-03-29 to 2024-06-14, indicating a change in the study details or results related to the Dapagliflozin at Discharge on Hospital Heart Failure Readmission clinical trial.
    Difference
    1.0%
    Check dated 2024-06-14T22:42:52.000Z thumbnail image
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the webpage content.
    Difference
    0.3%
    Check dated 2024-06-13T21:24:19.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:31:01.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 6 to 7, indicating a recent change in the number of medical and healthcare-related publications or documentation. This update may reflect new information or additional studies being added to the database.
    Difference
    0.3%
    Check dated 2024-05-22T21:00:12.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:14:53.000Z thumbnail image

Stay in the know with updates to Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin at Discharge Reduces Heart Failure Readmission Clinical Trial page.